FDA stresses birth defect risks with Roche drug

(AP) -- Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.

If you want to include this story in your blog, copy and paste this formatted text: